Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States

BACKGROUND: The introduction of oral direct-acting antivirals (DAAs) has dramatically changed the landscape of HCV treatment. However, a small percentage of patients fail to achieve sustained virologic response (SVR). Understanding the number of people who fail on DAAs and require re-treatment is im...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Aliment Pharmacol Ther
Main Authors: Chhatwal, Jagpreet, Chen, Qiushi, Ayer, Turgay, Bethea, Emily D., Kanwal, Fasiha, Kowdley, Kris V., Wang, Xiaojie, Roberts, Mark S., Gordon, Stuart C.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842132/
https://ncbi.nlm.nih.gov/pubmed/29377245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14527
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares